Adjust Font Size:

Press Releases

Robert Lanza, M.D., to Present at IBC Life Sciences’ Stem Cell Research Challenges Conference

Worcester, MA - Advanced Cell Technology, Inc.'s (OTC BB: ACTC) VP of Research & Scientific Development, Robert Lanza, M.D. will present at the Stem Cell Research Challenges Conference: "Obstacles to Overcome When Entering the Field of Stem Cell Therapeutics,” hosted by IBC Life Sciences, on Tuesday, November 8, 2005 at 11:00 AM PDT at the Radisson Hotel La Jolla in La Jolla, California.

Dr. Lanza's presentation will be titled "In Vivo Differentiation of Stem Cells and Their Progeny.” Dr. Lanza will discuss the developmental signals that instruct embryonic stem cells to choose a particular tissue pathway.

Dr. Lanza's slide presentation will be available on Advanced Cell Technology's website in the Conference Presentations section at "www.advancedcell.com/conference-presentations":http://www.advancedcell.com/conference-presentations.

IBC's Life Sciences Stem Cell Research Challenges Conference offers participating companies a focused look at the issues an organization must confront in moving into the field of stem cell research, and features presentations from leading researchers who are paving the way for the commercialization of stem cell therapeutics.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company is currently headquartered in Worcester, Massachusetts. For more information about the company visit "www.advancedcell.com":http://www.advancedcell.com

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and its subsidiary, Advanced Cell, Inc., and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2005.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

Press Contact


John Nesbett, Amanda Watkins
(212) 825-3210

Download PDF


11.08.05.pdf

To view PDF Files, you must have Acrobat Reader.

Download Adobe Acrobat